|
|
|
| Experience of Professor Huang Chunlin in the treatment of chronic erosive gastritis with five methods of invigorating spleen |
| GU Yewen1 WANG Zhike1 LI Hucai2 WANG Lixin2 |
1.The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510405, China;
2.Department of Nephrology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangdong Provincial Hospital of Chinese Medicine, Guangdong Province, Guangzhou 510120, China |
|
|
|
Abstract Chronic erosive gastritis is a kind of nonspecific inflammation of gastric mucosa caused by a variety of reasons, which is characterized by gastric mucosal erosion, hyperemia, edema and bleeding. It is a common clinical disease, with the characteristics of protracted, easy to repeat, reduce the life quality of patients. Professor Huang Chunlin is a famous expert of traditional Chinese medicine in China and a director of the national clinical research base of traditional Chinese medicine. He has rich clinical experience in the treatment of spleen and stomach disease. He thinks that the basic pathogenesis of the disease is spleen dyskinesia, and puts forward the theory of five methods of strengthening spleen to guide clinical practice. Professor Huang Chunlin often uses these five methods in clinical treatment, and the curative effect is good. By following Professor Huang Chunlin’s study, the author summarizes the commonly used drugs of “invigorating qi and strengthening spleen”“invigorating stomach and strengthening spleen”“clearing heat/warming cold and strengthening spleen”“regulating qi and strengthening spleen”“appetizing stomach and strengthening spleen”, so as to improve the clinical efficacy.
|
|
|
|
|
|
[1] Liu Y，Xu W，Wang GH，et al. A comparison of serum and plasma specimens in NMR-based metabonomics and its application in chronic atrophic gastritis rats [J]. Analytical Methods，2019，11（15）：115-118.
[2] Du Y，Bai Y，Xie P. Chronic gastritis in China：a national multi-center survey [J]. BMC Gastroenterol，2014，14：21.
[3] 于皆平，沈志祥，罗和生.实用消化病学[M].北京：科学出版社，2007：241.
[4] 董环，王彦刚，张晓梅.从“六位一体”论治慢性糜烂性胃炎[J].中华中医药杂志，2018，33（10）：4454-4456.
[5] 刘素贤.柏树纲教授以“相反相成”法配伍辨治慢性糜烂性胃炎学术经验总结[D].沈阳：辽宁中医药大学，2019.
[6] Shalikiani NV，Bakulin IG，Dubinkina VB，et al. Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis [J]. Terapevticheskii Arkhiv，2015，87（12）：59-65.
[7] Yan ZX，Dai YK，Ma T，et al. Efficacy of traditional Chinese medicine for chronic gastritis：a meta-analysis of randomized controlled trials [J]. Medicine，2019，98（20）：e15710.
[8] 申丽莎，郭淑云.糜烂性胃炎的中医诊疗进展[J].中医临床研究，2017，9（5）：136-139.
[9] 沈思源，刘欢，刘元元.慢性糜烂性胃炎合并幽门螺杆菌感染的临床及病理学分析[J].中国老年学杂志，2019，39（7）：1603-1605.
[10] 刘素贤，李玉锋，柏树纲，等.健脾益气清热燥湿法治疗慢性糜烂性胃炎疗效的Meta分析[J].中国中医基础医学杂志，2020，26（2）：217-222.
[11] 赵飞，赵克昌，赵晓超，等.自拟疏肝和胃汤治疗慢性糜烂性胃炎的疗效及复发率观察[J].四川中医，2020，38（8）：94-96.
[12] 黄帝内经·素问[M].太原：山西科学技术出版社，2011.
[13] 宋·陈言.三因极一病证方论[M].北京：人民卫生出版社，2007.
[14] 陈世超.冷炎教授治疗慢性糜烂性胃炎用药规律研究[D].长春：长春中医药大学，2020.
[15] 周平平，王彦刚，集川原，等.国医大师李佃贵以化浊解毒方治疗慢性糜烂性胃炎经验[J].中国中医药信息杂志，2020，27（1）：103-105.
[16] 黄帝内经·灵枢[M].太原：山西科学技术出版社，2019.
[17] 金·李东垣.脾胃论[M].北京：中国中医药出版社，2007.
[18] 清·唐容川.血证论[M].北京：中国中医药出版社，1996.
[19] 姜春兰，蔡锦源，梁莹，等.砂仁的有效成分及其药理作用的研究进展[J].轻工科技，2020，36（7）：43-45，47.
[20] 王晶，张世洋，盛永成，等.白术治疗胃肠道疾病药理作用研究进展[J].中华中医药学刊，2018，36（12）：2854-2858.
[21] 郭雪红.黄芪注射液的药理作用及临床应用研究进展[J].中国药房，2015，26（21）：3018-3021.
[22] 谢士敏，周长征.蒲公英药理作用及临床应用研究进展[J].辽宁中医药大学学报，2020，22（5）：138-142.
[23] 魏睦新，魏兰福，邹百仓，等.胃肠动力中药作用机制研究[J].中西医结合学报，2004（3）：163-166，171.
[24] 杨小红，陆锦，骆询，等.黄芩、黄连和大黄对幽门螺杆菌抑菌作用的研究进展[J].中国药房，2015，26（14）：2014-2016.
[25] 聂敏.益胃汤联合西药治疗幽门螺杆菌相关胃炎效果分析[J].当代医学，2015，21（12）：150-151.
[26] Wang T，Feng Y，Wang H，et al. The mechanisms of Sijunzi Decoction in the treatment of chronic gastritis revealed by network pharmacology [J]. Evid Based Complement Alternat Med，2020，2020：8850259.
[27] 何云山，谭周进，惠华英.保和丸研究进展[J].现代中药研究与实践，2020，34（1）：77-81. |
|
|
|
